Pfizer beats out Novo with $10B agreement to buy Metsera
After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has prevailed in its pursuit of obesity biotech Metsera.
https://www.fiercebiotech.com/biotech/pfizer-beats-out-novo-10b-agreement-buy-metsera
Bourla claims his new products are moving at the “speed of light.”
Full…
h/t A Deplorable Neanderthal